GlaxoSmithKline PLC (GSK) NewsBite - GSK Gets Approval To Sell Its H1N1 Vaccine
Posted: Thursday, November 12, 2009 2:11 PM EDT
By: Market Intelligence Center Staff
GlaxoSmithKline PLC (NYSE: GSK) opened at $41.77. So far today, the stock has hit a low of $41.44 and a high of $41.80. GSK is now trading at $41.57, up $0.34 (0.82%). The stock hit its 52-Week high of $42.18 last month and set its 52-Week low of $27.15 in March. GSK is trading higher today on news that has the company has received approval by U.S. regulators to sell its H1N1 vaccine. Technical indicators for the stock are neutral and S&P gives GSK a neutral 3 STARS (out of 5) hold ranking. If you are looking for a hedged play on GSK the stock seems like it could be a candidate for a January out-of-the-money bull-put credit spread below the 37.50 range. [ABR-Seven Summits Strategic Investments NewsBite]
CLICK HERE: FREE GlaxoSmithKline PLC (GSK) Stock ReportSee what our analysts have uncovered about GlaxoSmithKline PLC (GSK).